The Strategist

The long-term impact of Change hack, plus GLP-1s expand to CV

Posted By The Academy

March 21, 2024

This issue of The Strategist includes:

1. Change is finally back online, as health systems assess fallout

2. FDA approval and new partnerships expand reach of GLP-1 drugs

3. Mark Cuban Cost Plus Drugs partners with CHS

More Posts of Interest

Catalyst Website Images 2
The Strategist
Strategy Catalyst
Optum's Everycare: What we know; where they might go

May 12, 2022

Read Time - 10 minutes

Catalyst Website Images 2
The Strategist
Strategy Catalyst
The Strategist – In Brief, March 11, 2022

March 11, 2022

Read Time - 10 minutes

Catalyst Website Images 2
The Strategist
Strategy Catalyst
Walgreens moves more deeply into value-based care as Oak Street receives AARP endorsement

October 29, 2021

Read Time - 10 minutes